Commentary on Young et al.: Clinical guidance is required for stimulant co-prescription with opioid agonist therapy.
第一作者:
Nadine,Ezard
第一单位:
The National Centre for Clinical Research on Emerging Drugs, University of New South Wales, Randwick, New South Wales, Australia.;St Vincent's Hospital Alcohol and Drug Service, Sydney, Australia.;The National Drug and Alcohol Research Centre, University of New South Wales, Randwick, New South Wales, Australia.;New South Wales Drug and Alcohol Clinical Research and Improvement Network, New South Wales Ministry of Health, Sydney, Australia.
作者:
DOI
10.1111/add.70061
PMID
40181693
发布时间
2025-05-04
- 浏览0
Addiction (Abingdon, England)
1195-1197页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



